◆英語タイトル:curasan AG (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9792
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
curasan AG (curasan) develops, manufactures and commercializes medical devices in the field of regenerative medicine. The company offers a wide range of synthetic bone substitutes, dental and bone regeneration material products. It offers these products to orthopedic and spinal surgeons, oral and maxillofacial surgeons, and periodontists and dental implantologists in the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company has a research and development, and manufacturing facility in Frankfurt, Germany. The company offers its products through a network of distributors in the Americas, Europe, the Middle East and Asia. curasan is headquartered in Kleinostheim, Germany.
curasan AG (CUR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
curasan AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Curasan Enters into Distribution Agreement with implantcast 10
Equity Offering 11
Curasan to Raise USD6 Million in Private Placement of Shares 11
Curasan Raises USD1.2 Million in Private Placement of Shares 12
curasan to Raise USD4.6 Million in Rights Issue of Shares 13
curasan AG – Key Competitors 14
curasan AG – Key Employees 15
curasan AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
May 24, 2018: curasan concludes first quarter in line with annual guidance 17
Apr 26, 2018: Curasan Reports Full Year 2017 Financial Results 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
curasan AG, Pharmaceuticals & Healthcare, Key Facts, 2017 2
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8
curasan AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curasan Enters into Distribution Agreement with implantcast 10
Curasan to Raise USD6 Million in Private Placement of Shares 11
Curasan Raises USD1.2 Million in Private Placement of Shares 12
curasan to Raise USD4.6 Million in Rights Issue of Shares 13
curasan AG, Key Competitors 14
curasan AG, Key Employees 15
curasan AG, Subsidiaries 16
List of Figures
curasan AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
curasan AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
curasan AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
curasan AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
curasan AG, Medical Devices Deals, 2012 to YTD 2018 8